ProCE Banner Activity

CE / CME

Automation_Sanity_Copy_975_GI GICS 2019: CRC My Take on the Latest Developments in Colorectal Cancer at the 2019 Gastrointestinal Cancers Symposium

Clinical Thought

At the 2019 Gastrointestinal Cancers Symposium, important new clinical data were presented on molecular testing, novel immunotherapy strategies, short-course radiation, and low-dose regorafenib in colorectal cancer.

Pharmacists: 1.00 contact hour (1:0.0#### CEUs)

ABIM MOC: maximum of 1.00 Medical Knowledge MOC point

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: February 07, 2024

Expiration: February 06, 2025

Share

Faculty

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Provided by Postgraduate Institute for Medicine

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Bayer Healthcare Pharma

Taiho Oncology Inc

Partners

GRACE

ProCE Banner

Faculty Disclosure

Primary Author

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

John L. Marshall, MD, has disclosed that he has received consulting fees, fees for non-CME/CE services, and funds for research support from Amgen, Bayer, Celgene, Genentech, Merck, and Taiho.